Journal ArticleDOI
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.
Reads0
Chats0
TLDR
In this paper, a steering committee for standardizing diagnosis and management of peritoneal mesothelioma (PM) is established, which is a rare and aggressive malignancy characterized by widespread multiple metastatic tumour nodules originating from the peritoneum.Abstract:
Peritoneal mesothelioma (PM) is a rare and aggressive primary peritoneal malignancy characterized by widespread multiple metastatic tumour nodules originating from the peritoneum. The conventional classification distinguishes diffuse malignant peritoneal mesothelioma (DMPM) and border-line forms: multicystic peritoneal mesothelioma (MCPM) and well-differentiated papillary peritoneal mesothelioma (WDPPM). Despite the novel achievements in the management of PM, there is difficulty in conducting randomized trials due to its rarity and aggressive biology in many cases. As there is, a necessity to standardize diagnosis and management of PM, the Peritoneal Surface Oncology Group International (PSOGI) commissioned a steering committee to elaborate clinical guidelines.read more
Citations
More filters
Journal ArticleDOI
Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
Kanwal Pratap Singh Raghav,Suyu Liu,Michael J. Overman,Anneleis Willett,Mark Knafl,Szu-Chin Fu,Anais Malpica,Seema Prasad,Richard E. Royal,Christopher P. Scally,Paul F. Mansfield,Ignacio I. Wistuba,Andrew Futreal,Dipen M. Maru,Luisa M. Solis Soto,Edwin Roger Parra Cuentas,Honglei Chen,Pamela Villalobos,Anuj Verma,Armeen Mahvash,Patrick Hwu,Patricia Cortazar,Edward McKenna,Cindy Yun,Shannon Dervin,Katja Schulze,Walter C. Darbonne,Ajaykumar C. Morani,Scott Kopetz,Keith Fournier,Scott E. Woodman,James C. Yao,Gauri R. Varadhachary,Daniel M. Halperin +33 more
TL;DR: AtezoBev showed promising and durable efficacy in patients with advanced peritoneal mesothelioma with an acceptable safety profile, and these results address a grave unmet need for this orphan disease.
Journal ArticleDOI
The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases : a web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)
Vincent C J van de Vlasakker,Robin J. Lurvink,Peter H Cashin,Wim Ceelen,Marcello Deraco,Diane Goéré,Santiago González-Moreno,Kuno Lehmann,Yan Li,Brendan Moran,David L. Morris,Pompiliu Piso,Claudio Almeida Quadros,Beate Rau,S.P. Somashekhar,Antonio Sommariva,Kurt Van der Speeten,John Spiliotis,Paul H. Sugarbaker,Melissa Ching Ching Teo,Vic J. Verwaal,Yutaka Yonemura,Olivier Glehen,Ignace H. J. T. de Hingh +23 more
TL;DR: The PRODIGE 7 trial as mentioned in this paper investigated the additional value of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to cytoreductive surgery for patients with colorectal peritoneal metastases (CPM).
Journal ArticleDOI
Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.
Olivier Glehen,Vahan Kepenekian,Olivier Bouché,L. Gladieff,Charles Honoré,Julio Abba,Karine Abboud,Catherine Arvieux,Naoual Bakrin,Jean-Baptiste Delhorme,Peggy Dartigues,Sylvaine Durand-Fontanier,Clarisse Eveno,J. Fontaine,Maximiliano Gelli,Diane Goéré,Frédéric Guyon,Jérémie H. Lefevre,R. Lo Dico,Frédéric Marchal,C. Nadeau,B. Paquette,Denis Pezet,Marc Pocard,P. Rousset,Olivia Sgarbura,Abdelkader Taibi,Jean-Jacques Tuech,Benoit You,Laurent Villeneuve +29 more
TL;DR: It is desirable to prioritize disease conditions for which cytoreduction surgery with or without associated hyperthermic intraoperative peritoneal chemotherapy (HIPEC) is the gold-standard treatment, and for which systemic chemotherapy cannot be a temporary or long-term alternative.
Journal ArticleDOI
Advances in the management of peritoneal malignancies
Vahan Kepenekian,Aditi Bhatt,Julie Anne Peron,Mohammad Alyami,Nazim Benzerdjeb,N. Bakrin,Claire Falandry,Guillaume Passot,Pascal Rousset,Olivier Glehen +9 more
TL;DR: Improvements in knowledge of the biology, assessment and classification, perioperative and surgical management, systemic treatment and pre-emptive management of peritoneal surface malignancies are comprehensively described.
Journal ArticleDOI
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
Álvaro Arjona-Sánchez,O. Aziz,Guillaume Passot,George I. Salti,Jesus Esquivel,K. Van der Speeten,Pompiliu Piso,D.-S. Nedelcut,Antonio Sommariva,Y. Yonemura,Kiran K. Turaga,C.R. Selvasekar,L. Rodriguez-Ortiz,J.M. Sánchez-Hidalgo,Ángela Casado-Adam,Sebastián Rufián-Peña,Javier Briceño,O. Glehen +17 more
TL;DR: Analysis of individual patient data demonstrates that L-CRS+HIPEC is a safe and feasible procedure in highly selected patients with limited peritoneal disease when performed at experienced centres, while short to midterm outcomes are encouraging in patients with less invasive histology.
References
More filters
Journal ArticleDOI
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
Nicholas J. Vogelzang,James J. Rusthoven,James T. Symanowski,Claude Denham,E. Kaukel,Pierre Ruffié,Ulrich Gatzemeier,Michael Boyer,Salih Emri,Christian Manegold,Clet Niyikiza,Paolo Paoletti +11 more
TL;DR: Treatment with pemetrexed plus cisplatin and vitamin supplementation resulted in superior survival time, time to progression, and response rates compared with treatment with cis Platin alone in patients with malignant pleural mesothelioma.
Journal ArticleDOI
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.
TL;DR: The 2015 WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart features the incorporation of many exciting new advances in thoracic tumor diagnosis and classification.
Journal ArticleDOI
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan,Marcello Deraco,Dario Baratti,Shigeki Kusamura,Dominique Elias,Olivier Glehen,François Noël Gilly,Edward A. Levine,Perry Shen,Faheez Mohamed,Brendan Moran,David L. Morris,Terence C. Chua,Pompiliu Piso,Paul H. Sugarbaker +14 more
TL;DR: CRS combined with HIPEC achieved prolonged survival in selected patients with DMPM, and four prognostic factors were independently associated with improved survival in the multivariate analysis.
Journal ArticleDOI
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
Armin Rump,Yoshihiro Morikawa,Minoru Tanaka,Sawako Minami,Naohiko Umesaki,Masaki Takeuchi,Atsushi Miyajima,Atsushi Miyajima +7 more
TL;DR: The data indicate that mesothelin is a novel CA125-binding protein and that CA125 might contribute to the metastasis of ovarian cancer to the peritoneum by initiating cell attachment to the mesothelial epithelium via binding to Mesothelin.
Journal ArticleDOI
Results of the Two Incidence Screenings in the National Lung Screening Trial
Denise R. Aberle,Sarah DeMello,Christine D. Berg,William C. Black,Brenda K. Brewer,Timothy R. Church,Kathy L. Clingan,Fenghai Duan,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,David S. Gierada,Amanda Jain,Gordon C. Jones,Irene Mahon,Pamela M. Marcus,Joshua M. Rathmell,Jo Rean D. Sicks +17 more
TL;DR: Low-dose CT was more sensitive in detecting early-stage lung cancers, but its measured positive predictive value was lower than that of radiography, and the two annual incidence screenings with low- dose CT resulted in a decrease in the number of advanced-stage cancers diagnosed and an increase in thenumber of early-Stage lung cancers diagnosed.
Related Papers (5)
Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Terence C. Chua,B. J. Moran,Paul H. Sugarbaker,Edward A. Levine,Olivier Glehen,François Noël Gilly,Dario Baratti,Marcello Deraco,Dominique Elias,Armando Sardi,Winston Liauw,Tristan D. Yan,P. Barrios,Alberto Gomez Portilla,Ignace H J T de Hingh,Wim Ceelen,Joerg O.W. Pelz,Pompiliu Piso,Santiago González-Moreno,Kurt Van der Speeten,David L. Morris +20 more
Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.
Kim Govaerts,Robin J. Lurvink,I.H.J.T. de Hingh,K. Van der Speeten,Laurent Villeneuve,S. Kusamura,Vahan Kepenekian,M. Deraco,O. Glehen,B. J. Moran,Pedro Barrios-Sanchez,Joel M. Baumgartner,Almog Ben-Yaacov,Rosella Bertulli,Peter H Cashin,Tom Cecil,Sanjeev Dayal,Michele De Simone,Jason M. Foster,Diane Goéré,Kuno Lehmann,Yan Li,Brian W. Loggie,Faheez Mohamed,David L. Morris,Aviram Nissan,Pompiliu Piso,Marc Pocard,Beate Rau,Marc A. Reymond,Lucas Sideris,John Spiliotis,Paul H. Sugarbaker,Victor J. Verwaal,Malcom S. Wilson,Yutaka Yonemura,Yang Yu +36 more
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Willemien J. van Driel,Simone N. Koole,Karolina Sikorska,Jules H. Schagen van Leeuwen,Henk W.R. Schreuder,Ralph H. Hermans,Ignace H. J. T. de Hingh,Jacobus van der Velden,Henriette J. G. Arts,Leon F.A.G. Massuger,Arend G. J. Aalbers,Victor J. Verwaal,Jacobien M. Kieffer,Koen Van de Vijver,Harm van Tinteren,Neil K. Aaronson,Gabe S. Sonke +16 more